ABBVIE FDA Approval NDA 012418

NDA 012418

ABBVIE

FDA Drug Application

Application #012418

Documents

Letter2001-07-23
Letter2001-07-23
Letter2001-07-23
Letter2001-07-23

Application Sponsors

NDA 012418ABBVIE

Marketing Status

Discontinued002

Application Products

002INJECTABLE;INJECTION5MG/ML0AKINETONBIPERIDEN LACTATE

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP1961-04-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1976-01-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1979-10-18STANDARD
LABELING; LabelingSUPPL6AP2001-07-23STANDARD
LABELING; LabelingSUPPL7AP2001-07-23STANDARD
LABELING; LabelingSUPPL8AP2001-07-23STANDARD
LABELING; LabelingSUPPL9AP2001-07-23STANDARD

Submissions Property Types

ORIG1Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

ABBVIE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 12418
            [companyName] => ABBVIE
            [docInserts] => ["",""]
            [products] => [{"drugName":"AKINETON","activeIngredients":"BIPERIDEN LACTATE","strength":"5MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AKINETON","submission":"BIPERIDEN LACTATE","actionType":"5MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.